These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33185560)

  • 1. Once Daily Versus Overnight and Symptom Versus Physiological Monitoring to Detect Exacerbations of Chronic Obstructive Pulmonary Disease: Pilot Randomized Controlled Trial.
    Al Rajeh AM; Aldabayan YS; Aldhahir A; Pickett E; Quaderi S; Alqahtani JS; Mandal S; Lipman MC; Hurst JR
    JMIR Mhealth Uhealth; 2020 Nov; 8(11):e17597. PubMed ID: 33185560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbations in Chronic Obstructive Pulmonary Disease: Identification and Prediction Using a Digital Health System.
    Shah SA; Velardo C; Farmer A; Tarassenko L
    J Med Internet Res; 2017 Mar; 19(3):e69. PubMed ID: 28270380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study.
    Hurst JR; Donaldson GC; Quint JK; Goldring JJ; Patel AR; Wedzicha JA
    BMC Pulm Med; 2010 Oct; 10():52. PubMed ID: 20961450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of oxygen saturation variability analysis for the detection of exacerbation in individuals with COPD: A proof-of-concept study.
    Al Rajeh A; Bhogal AS; Zhang Y; Costello JT; Hurst JR; Mani AR
    Physiol Rep; 2021 Dec; 9(23):e15132. PubMed ID: 34851045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations.
    Yoon S; Kim TE; Kim TH; Na JO; Shin KC; Rhee CK; Jung SS; Choe KH; Yoo KH
    J Korean Med Sci; 2020 Jan; 35(2):e10. PubMed ID: 31920016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory pulse oximetry monitoring in Japanese COPD outpatients not receiving oxygen therapy.
    Minami S; Yamamoto S; Ogata Y; Nakatani T; Takeuchi Y; Hamaguchi M; Koba T; Komuta K
    Multidiscip Respir Med; 2014; 9(1):24. PubMed ID: 24739130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Smart Mobile Health Tool Versus a Paper Action Plan to Support Self-Management of Chronic Obstructive Pulmonary Disease Exacerbations: Randomized Controlled Trial.
    Boer L; Bischoff E; van der Heijden M; Lucas P; Akkermans R; Vercoulen J; Heijdra Y; Assendelft W; Schermer T
    JMIR Mhealth Uhealth; 2019 Oct; 7(10):e14408. PubMed ID: 31599729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implementation of an algorithm for predicting exacerbations in patients with COPD in telemonitoring: a study protocol for a single-blinded randomized controlled trial.
    Secher PH; Hangaard S; Kronborg T; Hæsum LKE; Udsen FW; Hejlesen O; Bender C
    Trials; 2022 Apr; 23(1):356. PubMed ID: 35473589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
    Cazzola M; D'Amato M; Califano C; Di Perna F; Calderaro E; Matera MG; D'Amato G
    Clin Ther; 2002 Apr; 24(4):595-604. PubMed ID: 12017404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance and Utility of a Smartphone App for the Detection of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease: Cohort Study.
    Rodriguez Hermosa JL; Fuster Gomila A; Puente Maestu L; Amado Diago CA; Callejas González FJ; Malo De Molina Ruiz R; Fuentes Ferrer ME; Álvarez Sala-Walther JL; Calle Rubio M
    JMIR Mhealth Uhealth; 2020 Mar; 8(3):e15699. PubMed ID: 32191213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of ACCESS: an automated tool to support self-management of COPD exacerbations.
    Boer LM; van der Heijden M; van Kuijk NM; Lucas PJ; Vercoulen JH; Assendelft WJ; Bischoff EW; Schermer TR
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3255-3267. PubMed ID: 30349231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.
    Dransfield MT; Bourbeau J; Jones PW; Hanania NA; Mahler DA; Vestbo J; Wachtel A; Martinez FJ; Barnhart F; Sanford L; Lettis S; Crim C; Calverley PM
    Lancet Respir Med; 2013 May; 1(3):210-23. PubMed ID: 24429127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
    Criner GJ; Connett JE; Aaron SD; Albert RK; Bailey WC; Casaburi R; Cooper JA; Curtis JL; Dransfield MT; Han MK; Make B; Marchetti N; Martinez FJ; Niewoehner DE; Scanlon PD; Sciurba FC; Scharf SM; Sin DD; Voelker H; Washko GR; Woodruff PG; Lazarus SC; ;
    N Engl J Med; 2014 Jun; 370(23):2201-10. PubMed ID: 24836125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: A randomized controlled cross-over trial.
    Pilcher J; Eastlake L; Richards M; Power S; Cripps T; Bibby S; Braithwaite I; Weatherall M; Beasley R
    Respirology; 2017 Aug; 22(6):1149-1155. PubMed ID: 28470831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
    Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA
    Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.